1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NCK2 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA SNX25 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA CCNA2 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA SLC30A1 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA PLXNB1 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA CD46 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA RNF115 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA ELP5 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA HUWE1 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA CKAP5 CTRPv2 pan-cancer AAC -0.13 0.0003
Download CSV